Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002274,GO:0002274,myeloid leukocyte activation,12/110,232/18800,1.13748619710646e-08,1.43750759982774e-05,8.84771117869159e-06,CD74/CSF1/HAVCR1/HAVCR2/IFNGR1/LGALS9/LTBR/NECTIN2/PTGDS/TGFBR2/TNF/VSIG4,12
GO:0046718,GO:0046718,viral entry into host cell,10/110,146/18800,1.41480520631132e-08,1.43750759982774e-05,8.84771117869159e-06,BSG/CD74/EPHA2/HAVCR1/LGALS9/NECTIN2/NECTIN4/SCARB2/TNFRSF14/TNFRSF4,10
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,13/110,291/18800,1.55462249440635e-08,1.43750759982774e-05,8.84771117869159e-06,CD27/CD5/CD74/CD83/FSTL3/HAVCR2/HLA-E/LGALS9/PLAUR/SIRPB1/TGFBR2/TNF/TNFRSF14,13
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,11/110,233/18800,1.21516743875152e-07,4.30113445609166e-05,2.64730394557761e-05,CD74/CSF1/HAVCR2/HLA-E/LGALS9/TGFBR2/TNFRSF13B/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,11
GO:0001503,GO:0001503,ossification,14/110,420/18800,1.62500142550373e-07,4.30113445609166e-05,2.64730394557761e-05,ATRAID/BAMBI/CSF1/EPHA2/FGF23/FGFR2/FSTL3/ITGA11/NELL1/NPPC/SPP1/TNF/TNFRSF11A/YAP1,14
GO:0002696,GO:0002696,positive regulation of leukocyte activation,14/110,421/18800,1.67279797441389e-07,4.30113445609166e-05,2.64730394557761e-05,CD27/CD5/CD74/CD83/HAVCR1/HAVCR2/HLA-E/LGALS9/NECTIN2/SIRPB1/TGFBR2/TNF/TNFRSF14/TNFRSF4,14
GO:0001649,GO:0001649,osteoblast differentiation,11/110,241/18800,1.70823722551997e-07,4.30113445609166e-05,2.64730394557761e-05,ATRAID/BAMBI/EPHA2/FGF23/FGFR2/ITGA11/NELL1/NPPC/SPP1/TNF/YAP1,11
GO:0002519,GO:0002519,natural killer cell tolerance induction,3/110,3/18800,1.94912053118569e-07,4.30113445609166e-05,2.64730394557761e-05,HAVCR2/HLA-E/LGALS9,3
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,13/110,381/18800,3.56507300725576e-07,6.18094532632967e-05,3.80430816958476e-05,CD27/CD5/CD74/CD83/HAVCR2/HLA-E/JAM2/LGALS9/SIRPB1/TGFBR2/TNF/TNFRSF14/VSIG4,13
GO:0050870,GO:0050870,positive regulation of T cell activation,10/110,223/18800,7.51342607674823e-07,0.0001127065972121,6.93697494319866e-05,CD27/CD5/CD74/CD83/HAVCR2/HLA-E/LGALS9/SIRPB1/TGFBR2/TNFRSF14,10
GO:0050863,GO:0050863,regulation of T cell activation,12/110,342/18800,7.71962994603797e-07,0.0001127065972121,6.93697494319866e-05,CD27/CD5/CD74/CD83/HAVCR2/HLA-E/LGALS9/SIRPB1/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,12
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,10/110,230/18800,9.95529485255464e-07,0.0001298499666376,7.99213166949515e-05,CD74/HAVCR2/HLA-E/LGALS9/TGFBR2/TNFRSF13B/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,10
GO:0043410,GO:0043410,positive regulation of MAPK cascade,14/110,491/18800,1.06003967989043e-06,0.0001298499666376,7.99213166949515e-05,CD27/CD74/EFNA1/FGF23/FGFR2/GDF15/HAVCR2/IGFBP4/IGFBP6/LGALS9/LTBR/TNF/TNFRSF11A/TNFRSF19,14
GO:0002697,GO:0002697,regulation of immune effector process,12/110,353/18800,1.07662192958366e-06,0.0001298499666376,7.99213166949515e-05,CD59/CD74/HAVCR2/HLA-E/LGALS9/NECTIN2/SPON2/TNF/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,12
GO:0032943,GO:0032943,mononuclear cell proliferation,11/110,300/18800,1.49377026876558e-06,0.0001593737971367,9.809293019991e-05,CD74/CSF1/HAVCR2/HLA-E/LGALS9/TGFBR2/TNFRSF13B/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,11
GO:0019058,GO:0019058,viral life cycle,11/110,317/18800,2.54747250657128e-06,0.0002558718936399,0.0001574865144325,BSG/CD74/EPHA2/HAVCR1/LGALS9/NECTIN2/NECTIN4/SCARB2/TNF/TNFRSF14/TNFRSF4,11
GO:0050900,GO:0050900,leukocyte migration,12/110,384/18800,2.58270116147078e-06,0.0002558718936399,0.0001574865144325,B4GALT1/BSG/CCN3/CD74/CSF1/JAM2/LGALS9/NBL1/PGF/TNF/TNFRSF11A/TNFRSF14,12
GO:0033209,GO:0033209,tumor necrosis factor-mediated signaling pathway,7/110,107/18800,3.12127195111019e-06,0.0002985658066337,0.000183764178029,TNF/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4,7
GO:0044706,GO:0044706,multi-multicellular organism process,9/110,213/18800,4.48550479721659e-06,0.0004013803324993,0.0002470454594596,AMBP/B4GALT1/BSG/HAVCR2/IGFBP7/LGALS9/PGF/SPP1/TGFBR2,9
GO:0071675,GO:0071675,regulation of mononuclear cell migration,7/110,116/18800,5.34575595674015e-06,0.0004419186935834,0.0002719964030631,CCN3/CSF1/JAM2/LGALS9/NBL1/TNF/TNFRSF14,7
GO:0002685,GO:0002685,regulation of leukocyte migration,9/110,218/18800,5.41645118307008e-06,0.0004419186935834,0.0002719964030631,CCN3/CD74/CSF1/JAM2/LGALS9/NBL1/PGF/TNF/TNFRSF14,9
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,9/110,221/18800,6.05098359612245e-06,0.0004795836713041,0.0002951788088093,CD27/LTBR/TNF/TNFRSF10A/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B/YAP1,9
GO:0051048,GO:0051048,negative regulation of secretion,8/110,167/18800,6.22456208787155e-06,0.0004796370897709,0.0002952116873253,CCN3/CD74/FGF23/LGALS9/TFF2/TNF/TNFRSF1A/TNFRSF1B,8
GO:0032102,GO:0032102,negative regulation of response to external stimulus,12/110,429/18800,7.99184487936736e-06,0.0005735426904611,0.000353009617094,CCN3/HAVCR2/HLA-E/LGALS9/NBL1/RTN4R/SPP1/TAFA5/TNF/TNFRSF1A/TNFRSF1B/VSIG4,12
GO:0046651,GO:0046651,lymphocyte proliferation,10/110,296/18800,9.41834648732111e-06,0.0006531623288957,0.0004020146842746,CD74/HAVCR2/HLA-E/LGALS9/TGFBR2/TNFRSF13B/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,10
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,11/110,373/18800,1.19302165813379e-05,0.0007879623999197,0.0004849827392213,CD74/EFNA1/EPHA2/EPHB4/EPHB6/FGFR2/GFRA1/SPINK1/TNF/TNFRSF14/TNFRSF1A,11
GO:0048013,GO:0048013,ephrin receptor signaling pathway,5/110,52/18800,1.30654193902663e-05,0.0008114164226888,0.0004994184486021,EFNA1/EFNA4/EPHA2/EPHB4/EPHB6,5
GO:0007565,GO:0007565,female pregnancy,8/110,185/18800,1.31628475201861e-05,0.0008114164226888,0.0004994184486021,AMBP/BSG/HAVCR2/IGFBP7/LGALS9/PGF/SPP1/TGFBR2,8
GO:0031099,GO:0031099,regeneration,8/110,188/18800,1.47923067330946e-05,0.000873060827183,0.000537359944481,CCN3/FOLR1/PGF/RTN4R/SPP1/TGFBR2/TNF/YAP1,8
GO:0034612,GO:0034612,response to tumor necrosis factor,9/110,249/18800,1.5752777430131e-05,0.0009103792623163,0.0005603290568349,FABP4/IL18BP/TNF/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4,9
GO:0038061,GO:0038061,NIK/NF-kappaB signaling,7/110,141/18800,1.9221762626775e-05,0.0010664233905334,0.0006563726101185,CCN3/CD27/HAVCR2/LGALS9/TNF/TNFRSF10A/TNFRSF10B,7
GO:0033674,GO:0033674,positive regulation of kinase activity,12/110,476/18800,2.24889721959946e-05,0.0011770643183337,0.0007244709613089,CD74/CSF1/EFNA1/EPHA2/EPHB4/EPHB6/FGFR2/TGFBR2/TNF/TNFRSF10A/TNFRSF10B/TNFRSF11A,12
GO:0048638,GO:0048638,regulation of developmental growth,10/110,329/18800,2.34538871719107e-05,0.0011996591009945,0.0007383778172553,AGRN/CSF1/DLL1/FGFR2/GDF15/NPPC/RTN4R/SPP1/TGFBR2/YAP1,10
GO:0002718,GO:0002718,regulation of cytokine production involved in immune response,6/110,98/18800,2.37855986138064e-05,0.0011996591009945,0.0007383778172553,CD74/HLA-E/SPON2/TNF/TNFRSF14/TNFRSF1B,6
GO:0002064,GO:0002064,epithelial cell development,8/110,203/18800,2.57187495961987e-05,0.0012739966317831,0.0007841318015983,B4GALT1/COL18A1/DLL1/EPHA2/SDC1/TNF/TNFRSF1A/YAP1,8
GO:0002367,GO:0002367,cytokine production involved in immune response,6/110,100/18800,2.66827742153871e-05,0.0012755027672906,0.0007850588124864,CD74/HLA-E/SPON2/TNF/TNFRSF14/TNFRSF1B,6
GO:0090092,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,9/110,267/18800,2.73305723792863e-05,0.0012755027672906,0.0007850588124864,ACVRL1/BAMBI/CCN3/FOLR1/FSTL3/GDF15/NBL1/TGFBR2/VWC2,9
GO:0002573,GO:0002573,myeloid leukocyte differentiation,8/110,210/18800,3.27668336110192e-05,0.0014427808958248,0.0008880167772276,CD74/CSF1/EPHA2/FSTL3/LTBR/TGFBR2/TNF/TNFRSF11A,8
GO:0050830,GO:0050830,defense response to Gram-positive bacterium,6/110,104/18800,3.33285963251866e-05,0.0014445863469698,0.0008891280138067,EPHA2/HAVCR2/HLA-E/RNASE6/TNF/TNFRSF14,6
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,7/110,157/18800,3.83804097288045e-05,0.0015838772746952,0.0009748601447864,CD27/CD74/CD83/CSF1/LGALS9/TGFBR2/TNF,7
GO:1903708,GO:1903708,positive regulation of hemopoiesis,7/110,157/18800,3.83804097288045e-05,0.0015838772746952,0.0009748601447864,CD27/CD74/CD83/CSF1/LGALS9/TGFBR2/TNF,7
GO:0032633,GO:0032633,interleukin-4 production,4/110,33/18800,3.98324118371868e-05,0.0015838772746952,0.0009748601447864,CD83/HAVCR2/HLA-E/LGALS9,4
GO:0032673,GO:0032673,regulation of interleukin-4 production,4/110,33/18800,3.98324118371868e-05,0.0015838772746952,0.0009748601447864,CD83/HAVCR2/HLA-E/LGALS9,4
GO:0042060,GO:0042060,wound healing,11/110,429/18800,4.31728209727816e-05,0.0016867803574436,0.001038195932066,ACVRL1/B4GALT1/CD59/FGFR2/PLAUR/SDC1/TAFA5/TGFBR2/TNF/TNFRSF12A/YAP1,11
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/110,13/18800,5.34126559557803e-05,0.0020296809263196,0.0012492476994992,CST3/TNFRSF1A/TNFRSF1B,3
GO:0032103,GO:0032103,positive regulation of response to external stimulus,11/110,442/18800,5.65006037840532e-05,0.0020745901148014,0.0012768888423359,CD74/CSF1/FABP4/HAVCR2/HLA-E/LGALS9/NECTIN2/PGF/TNF/TNFRSF11A/TNFRSF1A,11
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,5/110,72/18800,6.4101774595094e-05,0.0022797220862409,0.0014031454573986,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0033002,GO:0033002,muscle cell proliferation,8/110,233/18800,6.82757524638021e-05,0.0023974295865137,0.001475593211143,CCN3/FGFR2/NPPC/OGN/TAFA5/TGFBR2/TNF/YAP1,8
GO:0030595,GO:0030595,leukocyte chemotaxis,8/110,236/18800,7.4665521519128e-05,0.0025258799596836,0.0015546530924778,BSG/CCN3/CD74/CSF1/LGALS9/NBL1/PGF/TNFRSF11A,8
GO:0002443,GO:0002443,leukocyte mediated immunity,11/110,457/18800,7.61430612035553e-05,0.0025448295395019,0.0015663163636292,CD27/CD74/HAVCR2/HLA-E/LGALS9/NECTIN2/PTGDS/SPON2/TNF/TNFRSF1B/ULBP2,11
GO:0050777,GO:0050777,negative regulation of immune response,7/110,179/18800,8.79929653804829e-05,0.0028382847205286,0.001746935004249,AMBP/CD59/HAVCR2/HLA-E/LGALS9/TNFRSF14/VSIG4,7
GO:0014028,GO:0014028,notochord formation,2/110,3/18800,0.0001013867529638,0.003160076996873,0.0019449948350958,EFNA1/EPHA2,2
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,8/110,251/18800,0.000114551560685,0.0034919343883564,0.0021492496406155,AMBP/CD27/COL6A3/CST3/PLAUR/SPINK1/TNF/WFDC2,8
GO:0003007,GO:0003007,heart morphogenesis,8/110,254/18800,0.0001243354627299,0.0037086728345479,0.0022826499213132,ACVRL1/DLL1/EFNA1/EPHB4/FGFR2/FOLR1/TGFBR2/YAP1,8
GO:0060443,GO:0060443,mammary gland morphogenesis,4/110,44/18800,0.0001257625738513,0.0037113338283381,0.0022842877355763,CSF1/EPHA2/FGFR2/TGFBR2,4
GO:0060562,GO:0060562,epithelial tube morphogenesis,9/110,328/18800,0.0001329968381605,0.0038659057147331,0.0023794251391861,ACVRL1/CSF1/DLL1/EPHA2/FGFR2/FOLR1/TGFBR2/TNF/YAP1,9
GO:0001946,GO:0001946,lymphangiogenesis,3/110,18/18800,0.0001491781380315,0.004115000186584,0.0025327402203313,ACVRL1/CLEC14A/EPHA2,3
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,3/110,18/18800,0.0001491781380315,0.004115000186584,0.0025327402203313,COLEC12/HAVCR2/TNF,3
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,4/110,46/18800,0.000149825169014,0.004115000186584,0.0025327402203313,HAVCR2/HLA-E/LGALS9/NECTIN2,4
GO:0031645,GO:0031645,negative regulation of nervous system process,3/110,19/18800,0.0001763955235463,0.0047050113684393,0.002895886024213,CCN3/JAM2/TNF,3
GO:0009612,GO:0009612,response to mechanical stimulus,7/110,201/18800,0.0001806907605461,0.0047295402753901,0.0029109833137338,LRP11/LTBR/TGFBR2/TNF/TNFRSF10A/TNFRSF10B/TNFRSF1A,7
GO:0045765,GO:0045765,regulation of angiogenesis,9/110,345/18800,0.0001941064464265,0.0050096000314585,0.0030833572082972,ACVRL1/DLL1/EFNA1/EPHA2/HSPG2/PGF/TAFA5/TGFBR2/TNF,9
GO:0001894,GO:0001894,tissue homeostasis,8/110,272/18800,0.0001986550060219,0.0050096000314585,0.0030833572082972,CSF1/JAM2/PIGR/SPP1/TFF2/TFF3/TNFRSF11A/YAP1,8
GO:0052548,GO:0052548,regulation of endopeptidase activity,10/110,426/18800,0.0002003167080933,0.0050096000314585,0.0030833572082972,AMBP/CD27/COL6A3/CST3/EFNA1/LGALS9/PLAUR/SPINK1/TNF/WFDC2,10
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,3/110,20/18800,0.000206641647398,0.0050096000314585,0.0030833572082972,EFNA1/IFNGR1/TNF,3
GO:0060425,GO:0060425,lung morphogenesis,4/110,50/18800,0.0002076798859472,0.0050096000314585,0.0030833572082972,FGFR2/TGFBR2/TNF/YAP1,4
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,7/110,211/18800,0.0002432293877423,0.0056226526799764,0.0034606847975265,ACVRL1/B4GALT1/FGFR2/PGF/SPINK1/TNF/YAP1,7
GO:0050673,GO:0050673,epithelial cell proliferation,10/110,443/18800,0.0002739299579823,0.0061213187490015,0.003767608625538,ACVRL1/B4GALT1/CCN3/EPHA2/FGFR2/IGFBP4/PGF/SPINK1/TNF/YAP1,10
GO:0031341,GO:0031341,regulation of cell killing,5/110,100/18800,0.0003029809727575,0.0065152652591421,0.0040100786439223,CD59/HAVCR2/HLA-E/LGALS9/NECTIN2,5
GO:0060664,GO:0060664,epithelial cell proliferation involved in salivary gland morphogenesis,2/110,5/18800,0.0003353736335633,0.0067873363350964,0.0041775355881783,FGFR2/TNF,2
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/110,5/18800,0.0003353736335633,0.0067873363350964,0.0041775355881783,TNFRSF1A/TNFRSF1B,2
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,4/110,57/18800,0.0003451940155675,0.0067873363350964,0.0041775355881783,CD27/CD74/EFNA1/LGALS9,4
GO:0032760,GO:0032760,positive regulation of tumor necrosis factor production,5/110,103/18800,0.0003474411534187,0.0067873363350964,0.0041775355881783,HAVCR2/HLA-E/IFNGR1/LGALS9/SPON2,5
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,6/110,161/18800,0.0003694962900058,0.0070688462653525,0.0043508020500139,CD74/HAVCR2/LGALS9/TNFRSF13B/TNFRSF14/VSIG4,6
GO:0008037,GO:0008037,cell recognition,7/110,228/18800,0.0003887469208626,0.0072374762313616,0.0044545920567937,B4GALT1/BSG/CD5/COLEC12/FOLR1/HAVCR2/SPON2,7
GO:0001911,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,3/110,25/18800,0.0004081256629205,0.0073515622658547,0.0045248108356606,HAVCR2/HLA-E/LGALS9,3
GO:0097305,GO:0097305,response to alcohol,7/110,235/18800,0.0004659348412657,0.0080483655950434,0.004953686106007,CD27/FGFR2/IGFBP7/NPPC/SPINK1/TGFBR2/TNF,7
GO:0071496,GO:0071496,cellular response to external stimulus,8/110,309/18800,0.0004671185511182,0.0080483655950434,0.004953686106007,ASGR1/DSC2/FGF23/FOLR1/LTBR/TNFRSF10A/TNFRSF10B/TNFRSF1A,8
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,6/110,170/18800,0.0004933313878569,0.0081946183827253,0.0050437031900658,FGFR2/NPPC/OGN/TAFA5/TGFBR2/TNF,6
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/110,6/18800,0.0005011361814913,0.0082153815978278,0.0050564827350497,HAVCR2/LGALS9,2
GO:0009991,GO:0009991,response to extracellular stimulus,10/110,479/18800,0.0005064276327428,0.0082153815978278,0.0050564827350497,ASGR1/DSC2/FGF23/FOLR1/GDF15/LRP11/SPINK1/SPP1/TGFBR2/TNF,10
GO:0061564,GO:0061564,axon development,10/110,479/18800,0.0005064276327428,0.0082153815978278,0.0050564827350497,BSG/EFNA1/EFNA4/EPHA2/EPHB4/EPHB6/FGFR2/FOLR1/RTN4R/SPP1,10
GO:0002675,GO:0002675,positive regulation of acute inflammatory response,3/110,27/18800,0.0005146315668778,0.0082999300379018,0.0051085214288607,HLA-E/TNF/TNFRSF11A,3
GO:0071772,GO:0071772,response to BMP,6/110,173/18800,0.0005410907404332,0.0086263546779412,0.0053094324318372,ACVRL1/BAMBI/FSTL3/GDF15/NBL1/VWC2,6
GO:0006959,GO:0006959,humoral immune response,8/110,317/18800,0.0005527837162666,0.0087324313650667,0.0053747215399151,CD59/CD83/HLA-E/RNASE6/SPON2/TNF/VSIG4/WFDC2,8
GO:0003170,GO:0003170,heart valve development,4/110,65/18800,0.0005708122753881,0.0087324313650667,0.0053747215399151,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0003416,GO:0003416,endochondral bone growth,3/110,28/18800,0.0005739411805449,0.0087324313650667,0.0053747215399151,FGFR2/NPPC/TGFBR2,3
GO:0033688,GO:0033688,regulation of osteoblast proliferation,3/110,28/18800,0.0005739411805449,0.0087324313650667,0.0053747215399151,ATRAID/FGFR2/NELL1,3
GO:0043534,GO:0043534,blood vessel endothelial cell migration,6/110,175/18800,0.0005748770337214,0.0087324313650667,0.0053747215399151,ACVRL1/CLEC14A/EFNA1/EPHA2/EPHB4/TNF,6
GO:0060249,GO:0060249,anatomical structure homeostasis,8/110,319/18800,0.0005760760417473,0.0087324313650667,0.0053747215399151,CSF1/JAM2/PIGR/SPP1/TFF2/TFF3/TNFRSF11A/YAP1,8
GO:0031622,GO:0031622,positive regulation of fever generation,2/110,7/18800,0.0006989081706739,0.0097334592539644,0.0059908438925094,TNF/TNFRSF11A,2
GO:0003143,GO:0003143,embryonic heart tube morphogenesis,4/110,70/18800,0.0007559160488389,0.0102288347291675,0.0062957423939246,DLL1/FOLR1/TGFBR2/YAP1,4
GO:0071260,GO:0071260,cellular response to mechanical stimulus,4/110,70/18800,0.0007559160488389,0.0102288347291675,0.0062957423939246,LTBR/TNFRSF10A/TNFRSF10B/TNFRSF1A,4
GO:0032496,GO:0032496,response to lipopolysaccharide,8/110,333/18800,0.0007623352220431,0.0102577262087886,0.0063135248019789,FGFR2/HAVCR2/IL18BP/LGALS9/SPON2/TNF/TNFRSF11A/TNFRSF1B,8
GO:0001906,GO:0001906,cell killing,6/110,185/18800,0.0007691445751362,0.0102577262087886,0.0063135248019789,CD59/HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,6
GO:0060055,GO:0060055,angiogenesis involved in wound healing,3/110,31/18800,0.0007775258309086,0.0102707459759082,0.0063215383345058,B4GALT1/TAFA5/TNF,3
GO:0002819,GO:0002819,regulation of adaptive immune response,6/110,188/18800,0.0008363227708579,0.0108409316185044,0.0066724817232247,HAVCR2/HLA-E/NECTIN2/TNF/TNFRSF14/TNFRSF1B,6
GO:0003149,GO:0003149,membranous septum morphogenesis,2/110,8/18800,0.0009283161712162,0.0115370170745491,0.0071009151500469,FGFR2/TGFBR2,2
GO:0033687,GO:0033687,osteoblast proliferation,3/110,33/18800,0.0009357710316415,0.0115370170745491,0.0071009151500469,ATRAID/FGFR2/NELL1,3
GO:0070227,GO:0070227,lymphocyte apoptotic process,4/110,75/18800,0.0009798822406559,0.0119219005946468,0.0073378069914306,CD27/CD74/EFNA1/LGALS9,4
GO:0048565,GO:0048565,digestive tract development,5/110,130/18800,0.0010029436303272,0.0120963723066426,0.007445192532681,CLMP/FGFR2/TGFBR2/TNF/YAP1,5
GO:0031348,GO:0031348,negative regulation of defense response,7/110,268/18800,0.0010102515258264,0.0121317650763748,0.0074669764178196,CCN3/HAVCR2/HLA-E/LGALS9/TNFRSF1A/TNFRSF1B/VSIG4,7
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,5/110,131/18800,0.0010379479295358,0.012357371487264,0.0076058348394271,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0003158,GO:0003158,endothelium development,5/110,133/18800,0.0011106691090205,0.0130550682560294,0.0080352600126284,ACVRL1/COL18A1/DLL1/TNF/TNFRSF1A,5
GO:0001763,GO:0001763,morphogenesis of a branching structure,6/110,199/18800,0.001122160678279,0.0131344882765652,0.0080841422170488,CSF1/EPHA2/FGFR2/TGFBR2/TNF/YAP1,6
GO:0031652,GO:0031652,positive regulation of heat generation,2/110,9/18800,0.0011889899583677,0.0133532718401305,0.0082188012464203,TNF/TNFRSF11A,2
GO:0090132,GO:0090132,epithelium migration,8/110,361/18800,0.0012799355630574,0.0141455826769775,0.0087064604037709,ACVRL1/CCN3/CLEC14A/EFNA1/EPHA2/EPHB4/TGFBR2/TNF,8
GO:0002478,GO:0002478,antigen processing and presentation of exogenous peptide antigen,3/110,38/18800,0.0014164958990062,0.0154699197789112,0.0095215762461177,CD74/CTSS/HLA-E,3
GO:0002291,GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/110,10/18800,0.0014805624883566,0.0157159225013119,0.0096729883873289,HAVCR2/LGALS9,2
GO:0003418,GO:0003418,growth plate cartilage chondrocyte differentiation,2/110,10/18800,0.0014805624883566,0.0157159225013119,0.0096729883873289,NPPC/TGFBR2,2
GO:0035050,GO:0035050,embryonic heart tube development,4/110,84/18800,0.0014942072220758,0.0157159225013119,0.0096729883873289,DLL1/FOLR1/TGFBR2/YAP1,4
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/110,370/18800,0.0014956753930592,0.0157159225013119,0.0096729883873289,CD27/CD74/HAVCR2/HLA-E/IL18BP/NECTIN2/TNF/TNFRSF1B,8
GO:0051346,GO:0051346,negative regulation of hydrolase activity,8/110,371/18800,0.0015213287448086,0.0159197344293589,0.0097984325292832,AMBP/CD27/COL6A3/CST3/PLAUR/SPINK1/TNF/WFDC2,8
GO:0033627,GO:0033627,cell adhesion mediated by integrin,4/110,86/18800,0.0016298604069651,0.0164408464324408,0.010119171598459,CCN3/EFNA1/EPHA2/ITGA11,4
GO:0002714,GO:0002714,positive regulation of B cell mediated immunity,3/110,41/18800,0.0017673059838793,0.0175089528545757,0.0107765800971888,HLA-E/NECTIN2/TNF,3
GO:0002891,GO:0002891,positive regulation of immunoglobulin mediated immune response,3/110,41/18800,0.0017673059838793,0.0175089528545757,0.0107765800971888,HLA-E/NECTIN2/TNF,3
GO:0001660,GO:0001660,fever generation,2/110,11/18800,0.0018026698743924,0.0175459867774197,0.0107993740951599,TNF/TNFRSF11A,2
GO:0031642,GO:0031642,negative regulation of myelination,2/110,11/18800,0.0018026698743924,0.0175459867774197,0.0107993740951599,JAM2/TNF,2
GO:0046598,GO:0046598,positive regulation of viral entry into host cell,2/110,11/18800,0.0018026698743924,0.0175459867774197,0.0107993740951599,CD74/LGALS9,2
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,2/110,11/18800,0.0018026698743924,0.0175459867774197,0.0107993740951599,CD74/LGALS9,2
GO:1900222,GO:1900222,negative regulation of amyloid-beta clearance,2/110,11/18800,0.0018026698743924,0.0175459867774197,0.0107993740951599,IFNGR1/TNF,2
GO:0030574,GO:0030574,collagen catabolic process,3/110,42/18800,0.0018952040678341,0.0182661360289002,0.0112426185401572,CST3/CTSS/MMP7,3
GO:0060485,GO:0060485,mesenchyme development,7/110,301/18800,0.0019639631561614,0.0187863234316956,0.0115627885273822,ACVRL1/BAMBI/EFNA1/FGFR2/FOLR1/TGFBR2/YAP1,7
GO:0014002,GO:0014002,astrocyte development,3/110,43/18800,0.0020287310175107,0.0192729446663521,0.0118622988839309,DLL1/IFNGR1/TNF,3
GO:1903035,GO:1903035,negative regulation of response to wounding,4/110,92/18800,0.0020878934415665,0.0196877235404985,0.0121175910077367,RTN4R/SPP1/TAFA5/TNF,4
GO:0050920,GO:0050920,regulation of chemotaxis,6/110,225/18800,0.0020936836497646,0.0196877235404985,0.0121175910077367,CCN3/CD74/CSF1/LGALS9/NBL1/PGF,6
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,3/110,44/18800,0.0021679726109492,0.0198197010399137,0.0121988217989375,MMP7/TNF/TNFRSF1B,3
GO:0098773,GO:0098773,skin epidermis development,4/110,93/18800,0.0021720220317713,0.0198197010399137,0.0121988217989375,DLL1/FGFR2/TNF/TNFRSF19,4
GO:0030856,GO:0030856,regulation of epithelial cell differentiation,5/110,157/18800,0.0023065321427664,0.0208321327735853,0.0128219631005029,ACVRL1/DLL1/TNF/TNFRSF1A/YAP1,5
GO:0046631,GO:0046631,alpha-beta T cell activation,5/110,158/18800,0.0023709889345684,0.0212851886876796,0.01310081434805,CD83/HLA-E/LGALS9/TGFBR2/TNFRSF14,5
GO:0002440,GO:0002440,production of molecular mediator of immune response,7/110,312/18800,0.0024024777620036,0.0214983010058005,0.0132319827842783,CD74/HLA-E/SPON2/TNF/TNFRSF14/TNFRSF1B/TNFRSF4,7
GO:0060070,GO:0060070,canonical Wnt signaling pathway,7/110,313/18800,0.0024458043214976,0.0217457089353667,0.0133842598160228,BAMBI/FGFR2/FOLR1/IGFBP4/IGFBP6/SDC1/YAP1,7
GO:0090287,GO:0090287,regulation of cellular response to growth factor stimulus,7/110,314/18800,0.0024897315431842,0.0219372934299484,0.0135021780986515,ACVRL1/BAMBI/DLL1/FOLR1/FSTL3/NBL1/VWC2,7
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/110,13/18800,0.0025370493095429,0.0219372934299484,0.0135021780986515,CST3/NPPC,2
GO:0060560,GO:0060560,developmental growth involved in morphogenesis,6/110,234/18800,0.0025464342049183,0.0219372934299484,0.0135021780986515,CSF1/FGFR2/RTN4R/SPP1/TGFBR2/YAP1,6
GO:0045747,GO:0045747,positive regulation of Notch signaling pathway,3/110,48/18800,0.0027837298639799,0.0232592368755434,0.0143158206701823,CCN3/DLL1/YAP1,3
GO:0032963,GO:0032963,collagen metabolic process,4/110,101/18800,0.0029309441433841,0.0241621175434555,0.0148715344194152,CST3/CTSS/MMP7/NPPC,4
GO:0048681,GO:0048681,negative regulation of axon regeneration,2/110,14/18800,0.002948609156355,0.0241621175434555,0.0148715344194152,RTN4R/SPP1,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/110,14/18800,0.002948609156355,0.0241621175434555,0.0148715344194152,TNFRSF1A/TNFRSF1B,2
GO:0060043,GO:0060043,regulation of cardiac muscle cell proliferation,3/110,49/18800,0.0029527605793912,0.0241621175434555,0.0148715344194152,FGFR2/TGFBR2/YAP1,3
GO:0006692,GO:0006692,prostanoid metabolic process,3/110,50/18800,0.0031279784959941,0.0249339435284127,0.0153465853614713,CD74/PTGDS/TNFRSF1A,3
GO:0006693,GO:0006693,prostaglandin metabolic process,3/110,50/18800,0.0031279784959941,0.0249339435284127,0.0153465853614713,CD74/PTGDS/TNFRSF1A,3
GO:2001238,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,3/110,50/18800,0.0031279784959941,0.0249339435284127,0.0153465853614713,LTBR/TNF/TNFRSF12A,3
GO:0045926,GO:0045926,negative regulation of growth,6/110,245/18800,0.0031955253574478,0.0253268209758869,0.0155883973827984,ACVRL1/CCN3/GDF15/RTN4R/SPP1/TGFBR2,6
GO:0006898,GO:0006898,receptor-mediated endocytosis,6/110,246/18800,0.0032601255889152,0.0256192305485859,0.0157683724622648,ASGR1/DLL1/FOLR1/HSPG2/SCARB2/TGFBR2,6
GO:0110148,GO:0110148,biomineralization,5/110,172/18800,0.0034170438970329,0.0264035648199704,0.0162511221257511,ATRAID/FGF23/FGFR2/NELL1/SPP1,5
GO:0031103,GO:0031103,axon regeneration,3/110,52/18800,0.0034972619467365,0.0268406549543556,0.0165201466003737,FOLR1/RTN4R/SPP1,3
GO:0048771,GO:0048771,tissue remodeling,5/110,174/18800,0.003589763564161,0.027432518256151,0.0168844323649971,ACVRL1/CST3/EPHA2/SPP1/TNFRSF11A,5
GO:0032526,GO:0032526,response to retinoic acid,4/110,109/18800,0.0038539062188489,0.0286972278822755,0.0176628481102914,FGFR2/IGFBP7/TNF/YAP1,4
GO:0045780,GO:0045780,positive regulation of bone resorption,2/110,16/18800,0.0038587116078185,0.0286972278822755,0.0176628481102914,SPP1/TNFRSF11A,2
GO:0051044,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/110,16/18800,0.0038587116078185,0.0286972278822755,0.0176628481102914,TNF/TNFRSF1B,2
GO:0060046,GO:0060046,regulation of acrosome reaction,2/110,16/18800,0.0038587116078185,0.0286972278822755,0.0176628481102914,B4GALT1/SPINK1,2
GO:0045927,GO:0045927,positive regulation of growth,6/110,256/18800,0.0039609981401607,0.0293791680235452,0.0180825752416007,AGRN/CSF1/DLL1/FGFR2/TGFBR2/YAP1,6
GO:0034205,GO:0034205,amyloid-beta formation,3/110,56/18800,0.0043131177531933,0.0308293324470323,0.0189751365040361,EFNA1/IFNGR1/TNF,3
GO:0002526,GO:0002526,acute inflammatory response,4/110,113/18800,0.0043817692170813,0.0308503243862529,0.0189880568263584,B4GALT1/HLA-E/TNF/TNFRSF11A,4
GO:0002832,GO:0002832,negative regulation of response to biotic stimulus,4/110,113/18800,0.0043817692170813,0.0308503243862529,0.0189880568263584,HAVCR2/HLA-E/LGALS9/VSIG4,4
GO:0030278,GO:0030278,regulation of ossification,4/110,118/18800,0.0051075630563023,0.0348117442707191,0.0214262699529869,ATRAID/CSF1/FGF23/NELL1,4
GO:0001818,GO:0001818,negative regulation of cytokine production,7/110,363/18800,0.0054973455016894,0.0358191016101942,0.022046288017203,CD83/DLL1/EPHA2/HAVCR2/LGALS9/TNF/VSIG4,7
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,HLA-E,1
GO:0002651,GO:0002651,positive regulation of tolerance induction to self antigen,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,TGFBR2,1
GO:0003147,GO:0003147,neural crest cell migration involved in heart formation,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,FOLR1,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,CST3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,DLL1,1
GO:0032712,GO:0032712,negative regulation of interleukin-3 production,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,HAVCR2,1
GO:0035602,GO:0035602,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,FGFR2,1
GO:0035603,GO:0035603,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,FGFR2,1
GO:0035604,GO:0035604,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,FGFR2,1
GO:0035607,GO:0035607,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,FGFR2,1
GO:0036325,GO:0036325,vascular endothelial growth factor receptor-3 signaling pathway,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,CLEC14A,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,AGRN,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,TNF,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,NECTIN2,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,CST3,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,DLL1,1
GO:0071656,GO:0071656,negative regulation of granulocyte colony-stimulating factor production,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,HAVCR2,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,TNF,1
GO:1901554,GO:1901554,response to paracetamol,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,TNF,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,CSF1,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/110,1/18800,0.0058510638297872,0.0358191016101942,0.022046288017203,TGFBR2,1
GO:0002837,GO:0002837,regulation of immune response to tumor cell,2/110,20/18800,0.0060171958725128,0.0358191016101942,0.022046288017203,HAVCR2/NECTIN2,2
GO:0042359,GO:0042359,vitamin D metabolic process,2/110,20/18800,0.0060171958725128,0.0358191016101942,0.022046288017203,FGF23/TNF,2
GO:0042177,GO:0042177,negative regulation of protein catabolic process,4/110,124/18800,0.0060798986001891,0.0361148580662197,0.0222283230688758,ATRAID/CST3/EFNA1/NELL1,4
GO:0002260,GO:0002260,lymphocyte homeostasis,3/110,65/18800,0.0065433343965225,0.0380528503479111,0.0234211373522225,CD74/LGALS9/TNFRSF13B,3
GO:0031100,GO:0031100,animal organ regeneration,3/110,65/18800,0.0065433343965225,0.0380528503479111,0.0234211373522225,PGF/TGFBR2/TNF,3
GO:0071300,GO:0071300,cellular response to retinoic acid,3/110,67/18800,0.0071160687414536,0.0404507678049026,0.0248970308426183,FGFR2/TNF/YAP1,3
GO:0002834,GO:0002834,regulation of response to tumor cell,2/110,22/18800,0.007260169405219,0.0406862826870255,0.0250419878261888,HAVCR2/NECTIN2,2
GO:0030277,GO:0030277,maintenance of gastrointestinal epithelium,2/110,22/18800,0.007260169405219,0.0406862826870255,0.0250419878261888,TFF2/TFF3,2
GO:0060445,GO:0060445,branching involved in salivary gland morphogenesis,2/110,22/18800,0.007260169405219,0.0406862826870255,0.0250419878261888,FGFR2/TNF,2
GO:2000810,GO:2000810,regulation of bicellular tight junction assembly,2/110,22/18800,0.007260169405219,0.0406862826870255,0.0250419878261888,EPHA2/TNF,2
GO:0002764,GO:0002764,immune response-regulating signaling pathway,8/110,482/18800,0.0073916478635762,0.0412110558879643,0.0253649803249262,BTN2A1/CD79B/COLEC12/CTSS/HAVCR2/NECTIN2/PIGR/TNF,8
GO:0061371,GO:0061371,determination of heart left/right asymmetry,3/110,68/18800,0.0074132360807837,0.0412110558879643,0.0253649803249262,DLL1/FOLR1/TGFBR2,3
GO:0016049,GO:0016049,cell growth,8/110,484/18800,0.0075699097627935,0.0419244975346664,0.0258040963082871,ACVRL1/CCN3/IGFBP4/IGFBP7/RTN4R/SPP1/TGFBR2/YAP1,8
GO:0043588,GO:0043588,skin development,6/110,296/18800,0.0079166535307971,0.0433413097778045,0.0266761296473263,DLL1/EPHA2/FGFR2/TNF/TNFRSF19/YAP1,6
GO:0002053,GO:0002053,positive regulation of mesenchymal cell proliferation,2/110,23/18800,0.0079214290040904,0.0433413097778045,0.0266761296473263,FGFR2/TGFBR2,2
GO:0046697,GO:0046697,decidualization,2/110,23/18800,0.0079214290040904,0.0433413097778045,0.0266761296473263,BSG/SPP1,2
GO:0042246,GO:0042246,tissue regeneration,3/110,72/18800,0.0086748616701353,0.0465427455812254,0.028646580401756,CCN3/TGFBR2/YAP1,3
GO:0009855,GO:0009855,determination of bilateral symmetry,4/110,138/18800,0.0088096301563499,0.0469959885648362,0.0289255467886633,DLL1/FOLR1/NBL1/TGFBR2,4
GO:0016064,GO:0016064,immunoglobulin mediated immune response,5/110,216/18800,0.0088323230849233,0.0470266108206861,0.0289443944716551,CD27/CD74/HLA-E/NECTIN2/TNF,5
GO:0150076,GO:0150076,neuroinflammatory response,3/110,73/18800,0.0090086971659569,0.047716021433497,0.0293687196012341,IFNGR1/TNF/TNFRSF1B,3
GO:0060284,GO:0060284,regulation of cell development,8/110,500/18800,0.0091153862057021,0.0479811790030699,0.0295319213535382,DLL1/NPPC/RTN4R/SPP1/TNF/TNFRSF1A/TNFRSF1B/YAP1,8
GO:0072073,GO:0072073,kidney epithelium development,4/110,140/18800,0.0092551808342218,0.0485328386278474,0.0298714621691529,DLL1/FGFR2/SDC1/YAP1,4
GO:0045662,GO:0045662,negative regulation of myoblast differentiation,2/110,25/18800,0.0093218690708264,0.0485708455789387,0.0298948550559855,DLL1/TNF,2
